Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Azenta Life Sciences logo — Unrivaled sample exploration and management that helps life...

Azenta Life Sciences

Unrivaled sample exploration and management that helps life science companies bring impactful therapies to market faster

Founded 1978 United States Burlington, United States 1261 employees Post-IPO Equity Total: $508.35M Biotechnology, Life Sciences

General Information

Company Name Azenta Life Sciences
Founded Year 1978
Location United States Burlington, United States
Employees 1261
Industries Biotechnology, Life Sciences
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Azenta Life Sciences. To contact Azenta Life Sciences, visit azenta.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Azenta Life Sciences

Azenta Life Sciences, founded in 1978, is a prominent player in the Biotechnology and Life Sciences industries, with a mission reflected in its slogan: "Unrivaled sample exploration and management that helps life science companies bring impactful therapies to market faster."

Headquartered in the United States, Azenta offers comprehensive solutions in cold-chain sample management and genomic services. These offerings play a crucial role in accelerating drug development, clinical research, and advanced cell therapies. The company boasts a global presence, with operations extending across North America, Europe, and Asia.

In terms of financial backing, Azenta received a substantial $500.00M Post-IPO Equity investment from JP Morgan Chase on 23 November 2022. This investment underpins the company's solid market position and signifies confidence from leading financial institutions.

Taxonomy: Life Sciences, Sample Management, Genomic Services, Cold-Chain Solutions, Drug Development, Clinical Research, Cell Therapies, Pharmaceutical, Biotech, Academic Institutions, Healthcare Institutions, Global Operations, Therapy Acceleration, Biomedical Technology, Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $500.00M 1
JP Morgan Chase
23 Nov 2022
Venture Round $5.85M 1
Brooks Automation
12 Mar 2014
Venture Round $2.50M 1
BroadOak Capital Partners
BroadOak Capital Partners
04 Dec 2012

Azenta Life Sciences Alternatives & Competitors

View All Alternatives
Azenta Life Sciences vs
PROGEN
PROGEN Germany

Making life sciences better. Together.

41 employees
Biotechnology, Health and Wellness
Azenta Life Sciences vs
CapitalBio Technology
CapitalBio Technology China

Stick to Technological Innovation, Build The Dream of Health

Private Equity
5 employees
Biotechnology, Health Care
Azenta Life Sciences vs
N1 Life
N1 Life United States

Drug Delivery Innovation for Drug Development Revolution

Seed
10 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Azenta Life Sciences

Unrivaled sample exploration and management that helps life science companies bring impactful therapies to market faster
Azenta Life Sciences was founded in 1978.
Azenta Life Sciences is headquartered in Burlington, United States.
Azenta Life Sciences operates in Biotechnology and Life Sciences. Its work centres on Life Sciences, Sample Management, Genomic Services and Cold-Chain Solutions.
Azenta Life Sciences has approximately 1261 employees.
Azenta Life Sciences has completed 3 funding rounds, raising a total of $508.35M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Azenta Life Sciences include PROGEN, CapitalBio Technology, N1 Life, Intelligencia AI, TRELYS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Azenta Life Sciences and PROGEN are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Azenta Life Sciences, https://bouncewatch.com/company/azenta-life-sciences, updated 8 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes